Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: ILMN GH TXG CRSP QGEN TWST CDNA FLGT ONC FATE

| Held by: ARKK ARKG IWM VTI IWN VXF IBB SCHA VTWO PRFZ

Index	RUT	P/E	-	EPS (ttm)	-2.18	Insider Own	10.36%	Shs Outstand	301.85M	Perf Week	-6.79%
Market Cap	538.88M	Forward P/E	-	EPS next Y	-0.53	Insider Trans	-0.10%	Shs Float	270.64M	Perf Month	12.26%
Enterprise Value	940.01M	PEG	-	EPS next Q	-0.15	Inst Own	57.65%	Short Float	12.01%	Perf Quarter	45.11%
Income	-502.43M	P/S	3.49	EPS this Y	-64.88%	Inst Trans	-13.24%	Short Ratio	3.98	Perf Half Y	62.26%
Sales	154.58M	P/B	14.93	EPS next Y	71.12%	ROA	-44.60%	Short Interest	32.51M	Perf YTD	-2.46%
Book/sh	0.12	P/C	1.80	EPS next 5Y	25.32%	ROE	-205.41%	52W High	2.66 -32.90%	Perf Year	-22.40%
Cash/sh	0.99	P/FCF	-	EPS past 3/5Y	-21.38% -23.55%	ROIC	-68.31%	52W Low	0.85 109.72%	Perf 3Y	-78.80%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	5.67% 11.12%	Gross Margin	-210.02%	Volatility	9.53% 9.26%	Perf 5Y	-87.02%
Dividend TTM	-	EV/Sales	6.08	EPS Y/Y TTM	-16.00%	Oper. Margin	-357.07%	ATR (14)	0.17	Perf 10Y	-75.48%
Dividend Ex-Date	-	Quick Ratio	5.40	Sales Y/Y TTM	-10.72%	Profit Margin	-325.02%	RSI (14)	49.27	Recom	2.27
Dividend Gr. 3/5Y	- -	Current Ratio	6.24	EPS Q/Q	43.24%	SMA20	-7.37%	Beta	2.34	Target Price	2.11
Payout	-	Debt/Eq	19.40	Sales Q/Q	-3.82%	SMA50	13.13%	Rel Volume	0.64	Prev Close	1.86
Employees	575	LT Debt/Eq	19.38	Earnings	Nov 05 AMC	SMA200	30.04%	Avg Volume	8.17M	Price	1.78
IPO	Oct 27, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	14.02% -4.14%	Trades		Volume	3,409,141	Change	-4.04%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20
Oct-15-21	Resumed	Cowen	Market Perform	$30

Show Previous Ratings

Today 12:36AM	5 Revealing Analyst Questions From PacBio's Q3 Earnings Call (StockStory)
Nov-11-25 12:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory) +5.68%
Nov-10-25 10:35PM	Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3 (StockStory)
Nov-06-25 01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -7.05%
12:33AM	PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus (StockStory)
06:30PM	Loading…
Nov-05-25 06:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:54PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
04:02PM	PacBio Announces Third Quarter 2025 Financial Results (GlobeNewswire)
09:05AM	HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes (GlobeNewswire)
Nov-04-25 09:15AM	Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks) -10.71%
09:05AM	PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China (GlobeNewswire)
Nov-03-25 10:07PM	PacBio Earnings: What To Look For From PACB (StockStory)
Oct-31-25 02:11PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +20.62%
06:15PM	Loading…
Oct-28-25 06:15PM	Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -5.74%
Oct-24-25 02:36PM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Oct-22-25 04:05PM	PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire) +5.98%
Oct-21-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -4.04%: What You Should Know (Zacks)
Oct-20-25 10:10AM	PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations (Zacks) +20.73%
Oct-14-25 06:15PM	Pacific Biosciences of California (PACB) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) +9.43%
06:05AM	PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities (GlobeNewswire)
Oct-13-25 12:22PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +14.08%
09:05AM	PacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome Project (GlobeNewswire)
Oct-10-25 10:02AM	Here's Why You Should Retain PacBio Stock in Your Portfolio for Now (Zacks) -7.19%
Oct-08-25 12:44PM	PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell (Zacks) +7.86%
11:36AM	Why Is PacBio (PACB) Stock Soaring Today (StockStory)
09:05AM	Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity (GlobeNewswire)
Oct-07-25 09:05AM	PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs (GlobeNewswire) -7.89%
Oct-06-25 06:15PM	Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today (Zacks)
10:05AM	Loading…
Sep-30-25 10:05AM	PacBio Enters Carrier Screening Market With PureTarget Expansion (Zacks)
Sep-22-25 06:15PM	Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts (Zacks)
09:05AM	PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes (GlobeNewswire)
Sep-19-25 12:03AM	3 Reasons PACB is Risky and 1 Stock to Buy Instead (StockStory)
Sep-15-25 11:46AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Sep-14-25 11:36PM	Life Sciences Tools & Services Stocks Q2 Teardown: PacBio (NASDAQ:PACB) Vs The Rest (StockStory)
Sep-12-25 06:15PM	Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today (Zacks) -7.14%
Sep-05-25 12:30PM	PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq (Zacks)
Sep-03-25 09:05AM	PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow (GlobeNewswire)
Aug-22-25 02:25PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +9.52%
Aug-19-25 01:51PM	Cathie Woods ARK Innovation Sees Outflows, But Buys More Deere Stock Anyway (Barrons.com)
Aug-14-25 01:34AM	The Top 5 Analyst Questions From PacBio's Q2 Earnings Call (StockStory)
Aug-13-25 03:01PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +5.79%
Aug-11-25 09:38AM	PACB Q2 Deep Dive: International Demand, Consumables Growth, and Clinical Adoption Drive Results (StockStory) -6.67%
Aug-08-25 12:21PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +7.14%
12:07PM	PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises (Zacks)
Aug-07-25 07:30PM	Pacific Biosciences (PACB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) -8.70%
07:00PM	Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
05:58PM	Pacific Biosciences: Q2 Earnings Snapshot (Associated Press Finance)
05:07PM	PacBio (NASDAQ:PACB) Delivers Strong Q2 Numbers, Stock Soars (StockStory)
04:05PM	PacBio Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-06-25 05:50PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
09:00AM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-05-25 11:18PM	PacBio (PACB) Q2 Earnings Report Preview: What To Look For (StockStory)
Aug-04-25 09:15AM	Stay Ahead of the Game With Pacific Biosciences (PACB) Q2 Earnings: Wall Street's Insights on Key Metrics (Zacks)
09:05AM	Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models (GlobeNewswire)
Jul-31-25 12:03AM	3 Reasons to Avoid PACB and 1 Stock to Buy Instead (StockStory) -7.38%
Jul-29-25 06:15PM	Pacific Biosciences of California (PACB) Suffers a Larger Drop Than the General Market: Key Insights (Zacks) -6.10%
03:30PM	PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know (StockStory)
09:35AM	Pacific Biosciences (PACB) Jumps 6.5% Ahead of Earnings (Insider Monkey)
08:52AM	Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing (PR Newswire)
Jul-24-25 09:05AM	PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications (GlobeNewswire) -8.88%
Jul-23-25 01:11PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
09:05AM	PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio (GlobeNewswire)
Jul-22-25 04:05PM	QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels (Business Wire) +11.72%
Jul-21-25 04:05PM	PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire) +5.84%
Jul-17-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks) -6.71%
Jul-10-25 06:15PM	Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Jul-09-25 11:57AM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jul-08-25 12:00PM	Pacific Biosciences (PACB) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jul-03-25 09:08AM	Pacific Biosciences Targets Profitability by 2027 With Record Consumables Revenue (Insider Monkey) +7.38%
Jun-30-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks)
08:50AM	The 5 Most Interesting Analyst Questions From PacBio's Q1 Earnings Call (StockStory)
Jun-13-25 11:30AM	Why Is Steris (STE) Down 1.8% Since Last Earnings Report? (Zacks)
Jun-12-25 06:15PM	Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know (Zacks)
Jun-10-25 06:41AM	PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market Headwinds (StockStory)
Jun-05-25 12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jun-04-25 11:31PM	Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment (StockStory)
Jun-02-25 10:00AM	Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date (PR Newswire)
May-29-25 12:00PM	All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy (Zacks) -5.45%
May-28-25 09:00AM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) +20.85%
May-23-25 10:46AM	PacBio Stock Slips Despite New China Distribution Deal With Haorui (Zacks)
May-22-25 09:05AM	PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene (GlobeNewswire)
May-12-25 01:04PM	PACB Stock May Rise Following the Deal With Chulalongkorn University (Zacks)
10:56AM	PacBio Board Independent Investigation Concludes Allegations Unsubstantiated (GlobeNewswire)
May-09-25 12:00PM	PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates (Zacks) -6.67%
May-08-25 09:00PM	Pacific Biosciences (PACB) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks) +6.19%
05:30PM	Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:29PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	PacBio Announces First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 12:38PM	Pacific Biosciences of California Q1 2025 Earnings Preview (Seeking Alpha)
11:08AM	Earnings To Watch: Pacific Biosciences of California Inc (PACB) Reports Q1 2025 Result (GuruFocus.com)
May-05-25 09:05AM	First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand (GlobeNewswire)
Apr-29-25 06:15PM	Pacific Biosciences of California (PACB) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Apr-28-25 09:05AM	PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry (GlobeNewswire)
09:01AM	1 Volatile Stock to Target This Week and 2 to Keep Off Your Radar (StockStory)
Apr-23-25 06:15PM	Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know (Zacks)
Apr-22-25 09:05AM	Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa (GlobeNewswire)
Apr-09-25 02:38PM	PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know (StockStory) +20.83%
09:05AM	PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million (GlobeNewswire)

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Van Oene Mark	See Remarks	Aug 18 '25	Sale	1.31	26,836	35,182	1,920,035	Aug 20 04:06 PM
MARK VAN OENE	Officer	Aug 18 '25	Proposed Sale	1.31	26,836	35,174		Aug 18 04:07 PM
Farmer Michele	See Remarks	May 19 '25	Sale	1.00	5,195	5,200	269,259	May 21 04:09 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '25	Sale	1.41	12,497	17,583	2,225,357	Mar 05 04:37 PM
Van Oene Mark	See Remarks	Mar 03 '25	Sale	1.41	6,486	9,126	1,497,695	Mar 05 04:37 PM
Farmer Michele	See Remarks	Mar 03 '25	Sale	1.41	2,973	4,183	184,619	Mar 05 04:36 PM
MARK VAN OENE	Officer	Mar 03 '25	Proposed Sale	1.41	6,486	9,123		Mar 03 05:11 PM
CHRISTIAN HENRY	Officer	Mar 03 '25	Proposed Sale	1.41	12,497	17,578		Mar 03 05:06 PM
Farmer Michele	See Remarks	Feb 18 '25	Sale	1.88	24,349	45,727	187,592	Feb 19 05:00 PM
Van Oene Mark	See Remarks	Feb 18 '25	Sale	1.88	100,773	189,252	1,496,681	Feb 19 04:59 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '25	Sale	1.88	259,909	488,109	2,237,854	Feb 19 04:58 PM
CHRISTIAN HENRY	Officer	Feb 18 '25	Proposed Sale	1.88	259,909	488,109		Feb 18 05:59 PM
MARK VAN OENE	Officer	Feb 18 '25	Proposed Sale	1.88	100,773	189,252		Feb 18 05:56 PM
Van Oene Mark	See Remarks	Jan 10 '25	Sale	2.03	34,405	69,980	1,597,454	Jan 10 04:54 PM
MARK VAN OENE	Officer	Jan 10 '25	Proposed Sale	2.03	34,405	69,980		Jan 10 04:23 PM

Open in Screener

MRNA

Moderna Inc

Nov 12 • 01:36PM ET

26.61

+0.20 0.76 %

Healthcare • Biotechnology • USA • NASD

Peers: BNTX NVAX REGN ALNY INCY BMRN SRPT VRTX GILD BIIB

| Held by: VTI VOO VB RSP VBR XBI SPY IVV XLV IBB

Index	S&P 500	P/E	-	EPS (ttm)	-8.06	Insider Own	10.50%	Shs Outstand	391.00M	Perf Week	12.95%
Market Cap	10.40B	Forward P/E	-	EPS next Y	-6.92	Insider Trans	-0.00%	Shs Float	349.65M	Perf Month	1.37%
Enterprise Value	6.62B	PEG	-	EPS next Q	-2.63	Inst Own	72.90%	Short Float	18.21%	Perf Quarter	-0.30%
Income	-3.12B	P/S	4.66	EPS this Y	12.18%	Inst Trans	-0.22%	Short Ratio	5.65	Perf Half Y	10.78%
Sales	2.23B	P/B	1.12	EPS next Y	15.09%	ROA	-22.31%	Short Interest	63.66M	Perf YTD	-36.00%
Book/sh	23.86	P/C	2.31	EPS next 5Y	20.29%	ROE	-29.32%	52W High	48.92 -45.61%	Perf Year	-43.18%
Cash/sh	11.53	P/FCF	-	EPS past 3/5Y	- -42.94%	ROIC	-31.11%	52W Low	23.04 15.49%	Perf 3Y	-83.78%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-43.99% 121.86%	Gross Margin	38.93%	Volatility	6.13% 5.86%	Perf 5Y	-62.77%
Dividend TTM	-	EV/Sales	2.97	EPS Y/Y TTM	-38.95%	Oper. Margin	-155.15%	ATR (14)	1.52	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.73	Sales Y/Y TTM	-56.00%	Profit Margin	-139.61%	RSI (14)	53.35	Recom	2.89
Dividend Gr. 3/5Y	- -	Current Ratio	3.93	EPS Q/Q	-1673.01%	SMA20	2.62%	Beta	1.11	Target Price	38.42
Payout	-	Debt/Eq	0.08	Sales Q/Q	-45.44%	SMA50	2.68%	Rel Volume	0.70	Prev Close	26.41
Employees	5800	LT Debt/Eq	0.07	Earnings	Nov 06 BMO	SMA200	-6.49%	Avg Volume	11.26M	Price	26.61
IPO	Dec 07, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	72.79% 10.33%	Trades		Volume	5,130,147	Change	0.76%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142
Nov-29-23	Initiated	Canaccord Genuity	Hold	$82
Nov-03-23	Upgrade	HSBC Securities	Reduce → Hold	$89 → $69
Nov-02-23	Downgrade	Deutsche Bank	Hold → Sell	$125 → $60

Show Previous Ratings

Nov-10-25 10:31PM	Q3 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks (StockStory) +6.66%
09:48AM	Will Keytruda Aid MRK's Growth in 2026 After a Subdued Q3? (Zacks)
09:25AM	What Are Wall Street Analysts Target Price for Moderna Stock? (Barchart)
Nov-07-25 05:19PM	Earnings live: Earnings remain solid with peak reporting weeks in the rearview mirror, Disney results ahead (Yahoo Finance)
08:16AM	Earnings live: Block stock drops after earnings miss, Airbnb pops, Opendoor pitches turnaround plan (Yahoo Finance)
12:31AM	Loading…
12:31AM	MRNA Q3 Deep Dive: Cost Controls and Pipeline Progress Amid Declining COVID Vaccine Demand (StockStory)
Nov-06-25 10:30PM	Moderna (MRNA) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
04:40PM	Earnings live: Airbnb stock jumps, Opendoor pitches turnaround plan, Duolingo stock nosedives (Yahoo Finance)
04:14PM	Moderna Cuts Costs As Covid Vaccine Sales Decline; Shares Rise (Investor's Business Daily)
04:03PM	Stock market today: Dow, S&P 500, Nasdaq fall as Nvidia leads AI trade lower, jobs jitters reignite (Yahoo Finance)
03:29PM	Analyst Report: Moderna, Inc. (Morningstar Research)
02:16PM	Moderna's losses narrow, Coach-maker's outlook disappoints (Yahoo Finance Video)
02:15PM	Stock market today: Dow, S&P 500, Nasdaq sink as valuation concerns mount amid bleak jobs data (Yahoo Finance)
02:11PM	Moderna Inc (MRNA) Q3 2025 Earnings Call Highlights: Strategic Cost Reductions Amid Revenue ... (GuruFocus.com)
11:58AM	Moderna Q3 Earnings Beat, Stock Up on Revised '25 Spending Plans (Zacks)
11:16AM	Loading…
11:16AM	Modernas Quarter Wasnt As Bad as It Could Have Been. The Stock Is Up. (Barrons.com)
11:14AM	Earnings Data Deluge (Zacks)
10:36AM	Pre-Markets Improve on Big Earnings Morning (Zacks)
10:10AM	Mixed earnings results from Moderna, DoorDash are in focus as stocks trade lower (MarketWatch)
09:47AM	Moderna Posts Narrower Loss, Cost Cuts Boost Shares (Bloomberg)
09:37AM	Stock market today: Dow, S&P 500, Nasdaq waver as layoffs jump, key Tesla vote looms (Yahoo Finance)
09:37AM	Stock market today: Dow, S&P 500, Nasdaq sink as layoffs jump, AI concerns stay top of mind (Yahoo Finance)
09:37AM	Stock market today: Dow, S&P 500, Nasdaq sink as AI valuation concerns mount amid bleak jobs data (Yahoo Finance)
09:33AM	Moderna Gains on Sharp Cost Cuts as Covid Vaccine Declines (Bloomberg)
08:15AM	Moderna (MRNA) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:09AM	Earnings live: Moderna stock pops amid cost-cutting efforts, Snap stock soars, Duolingo plunges (Yahoo Finance)
08:08AM	Moderna (NASDAQ:MRNA) Posts Better-Than-Expected Sales In Q3, Stock Soars (StockStory)
07:39AM	Moderna revenue falls 45%, but still tops estimates (Investing.com)
07:29AM	Moderna Swings to a Loss. The Stock Jumps Anyway. (Barrons.com)
07:13AM	Moderna: Q3 Earnings Snapshot (Associated Press Finance)
07:09AM	Loading…
07:09AM	Moderna Swings to a Loss on Fewer Covid-19 Vaccine Sales (The Wall Street Journal)
07:00AM	Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates (ACCESSWIRE)
05:32AM	ConocoPhillips, Airbnb and Opendoor among a big eclectic batch of earnings (MarketWatch)
04:25AM	Stock Market Today: Dow, S&P 500 and Nasdaq called a fraction lower as valuation concerns linger; Qualcomm and Robinhood shares dip after earnings; Tesla vote on Musk pay due. (MarketWatch)
Nov-05-25 06:48PM	Stock market today: Dow, S&P 500, Nasdaq futures tick higher as tech worries persist, key Tesla vote looms (Yahoo Finance)
06:48PM	Stock market today: Dow, S&P 500, Nasdaq futures tick down with Supreme Court tariff case, Tesla shareholder meeting in focus (Yahoo Finance)
06:48PM	Stock market today: Dow, S&P 500, Nasdaq futures stall as tech worries persist, key Tesla vote looms (Yahoo Finance)
06:48PM	Stock market today: Dow, S&P 500, Nasdaq futures slip with Supreme Court tariff hearing, Tesla meeting in focus (Yahoo Finance)
06:48PM	Stock market today: Dow, S&P 500, Nasdaq futures regroup with Supreme Court tariff hearing, Tesla meeting in focus (Yahoo Finance)
06:48PM	Stock market today: Dow, S&P 500, Nasdaq futures pause with Supreme Court tariff hearing, Tesla vote in focus (Yahoo Finance)
04:15PM	Moderna Is Running Low on Cash. Its Earnings Are Thursday. (Barrons.com)
Nov-04-25 10:21PM	Moderna Earnings: What To Look For From MRNA (StockStory)
09:45AM	Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows (Associated Press Finance)
08:36AM	Should You Buy Moderna Stock Ahead of Q3 Earnings Report? (Zacks)
Nov-03-25 07:18PM	Analyst Report: Moderna, Inc. (Morningstar Research) -8.28%
01:20PM	Why Moderna (MRNA) Stock Is Falling Today (StockStory)
05:00AM	Tidmarsh resigns from CDER; Kenvue to sell to Kimberly-Clark (BioPharma Dive)
Oct-31-25 04:25PM	Why Moderna (MRNA) Stock Is Trading Lower Today (StockStory)
09:00AM	Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know (Zacks)
04:56AM	Strength Seen in Moderna (MRNA): Can Its 13.9% Jump Turn into More Strength? (Zacks)
Oct-30-25 07:19PM	Analyst Report: Moderna, Inc. (Morningstar Research) +13.93%
04:39PM	S&P 500 Gains and Losses Today: Meta Stock Drops After Earnings; Moderna Surges (Investopedia)
01:22PM	Moderna stock soars after report of potential buyout talks (Investing.com)
10:00AM	Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline (Zacks)
Oct-29-25 06:47PM	Analyst Report: Moderna, Inc. (Morningstar Research)
08:00AM	Analysts Name 9 'Left Out' Stocks With Huge Upside Ahead (Investor's Business Daily)
Oct-24-25 05:45PM	Moderna (MRNA) Outperforms Broader Market: What You Need to Know (Zacks)
Oct-23-25 04:13PM	Moderna Topples, Threatening Its 50-Day Line, After A Key Vaccine Bites The Dust (Investor's Business Daily)
02:42PM	Moderna Named a Top Employer by Science for Eleventh Consecutive Year (ACCESSWIRE)
02:24PM	Analyst Report: Moderna, Inc. (Morningstar Research)
10:23AM	Tesla, Zions Bancorp, Moderna: Top Analyst Calls (Yahoo Finance Video)
07:27AM	These Stocks Are Moving the Most Today: Tesla, D-Wave Quantum, IBM, Moderna, Molina Healthcare, American Airlines, and More (Barrons.com)
07:00AM	Moderna to Host Investor Event - Analyst Day (ACCESSWIRE)
Oct-22-25 05:50PM	Moderna (MRNA) Dips More Than Broader Market: What You Should Know (Zacks)
04:23PM	Moderna says CMV vaccine once seen as future blockbuster fails key study (BioPharma Dive)
04:05PM	Moderna Drops Vaccine for Birth Defects After Trial Failure (Barrons.com)
01:10PM	Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why. (Motley Fool)
11:12AM	Stock Market Today: Tesla and IBM Tumble After Earnings; Moderna Trial Misses (TheStreet)
09:53AM	Should You Buy Moderna Right Now? (Motley Fool)
Oct-21-25 03:34PM	Moderna Stock Is at a Crossroads. Is the Path Ahead One of Profit or Pain for MRNA? (Barchart)
05:05AM	These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall (Motley Fool)
Oct-20-25 03:14PM	Super Micro Is the S&P 500s Biggest Gainer. The Stock Could Break Out. (Barrons.com)
02:05PM	Stock Market Today: Dow Jumps, Apple Clears Entry As iPhone 17 Does This; These Gold Stocks Shine (Live Coverage) (Investor's Business Daily)
Oct-19-25 08:00AM	Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025 (ACCESSWIRE)
Oct-17-25 09:59AM	Moderna to Present Promising Phase 1/2 Clinical and Safety Data for Cancer Antigen Therapy mRNA-4359 at ESMO 2025 (Insider Monkey)
Oct-16-25 07:00AM	Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 (ACCESSWIRE)
Oct-15-25 04:08PM	Why Moderna Might Be a One-Hit Wonder (Motley Fool) +5.60%
Oct-14-25 05:50PM	Moderna (MRNA) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
05:27PM	R&D spending now can have big payoffs later for companies (TheStreet)
01:33PM	Top Novavax Shareholder Demands Company's Sale (Barrons.com)
Oct-13-25 12:21PM	Moderna (MRNA) Stock Trades Up, Here Is Why (StockStory)
Oct-10-25 08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
05:07AM	AstraZeneca ups investment in Virginia; Moderna vets launch VC fund (BioPharma Dive)
Oct-08-25 05:50PM	Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
Oct-07-25 06:14AM	Venture financing for mRNA-based vaccines declines 82% in 2025 YTD (Pharmaceutical Technology)
Oct-06-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Oct-03-25 11:48AM	Palantir, AI bubble comments, pharma stocks: Trending Tickers (Yahoo Finance Video)
Oct-02-25 05:50PM	Moderna (MRNA) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
10:32AM	Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency? (Zacks)
09:30AM	Moderna (MRNA) Recently Broke Out Above the 50-Day Moving Average (Zacks)
01:35AM	Brookline Reaffirms Price Target for Moderna (MRNA) After Strong mRNA-1283 Vaccine Results (Insider Monkey)
Oct-01-25 04:20PM	These Stocks Moved the Most Today: Nike, Netflix, Fermi, Moderna, AES, Lithium Americas, Sunrun, Corteva, and More (Barrons.com) +6.85%
02:48PM	Pharma stocks are powering the Nasdaq Composite and S&P 500 higher in afternoon trading (MarketWatch)
02:08PM	These Stocks Are Moving the Most Today: Nike, Netflix, Fermi, Moderna, AES, Lithium Americas, Sunrun, Corteva, and More (Barrons.com)
Sep-30-25 07:30AM	2 Beaten-Down Stocks to Buy and Hold for a Decade (Motley Fool)
Sep-25-25 05:50PM	Moderna (MRNA) Dips More Than Broader Market: What You Should Know (Zacks)
06:55AM	Moderna opens UK vaccine manufacturing facility (Pharmaceutical Technology)
05:34AM	Moderna opens new manufacturing and R&D facility in the UK (Investment Monitor)
Sep-24-25 07:31PM	Moderna's COVID-19 Vaccine Update Boosts Antibodies 16-Fold, Data Shows (Benzinga)
07:01PM	Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK (ACCESSWIRE)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hussain Abbas	Director	Jun 11 '25	Sale	28.00	312	8,736	580	Jun 12 04:22 PM
Hussain Abbas	Director	Jun 11 '25	Proposed Sale	28.00	312	8,736		Jun 11 10:06 AM
Bancel Stephane	Chief Executive Officer	Mar 03 '25	Buy	31.22	160,314	5,004,318	9,210,686	Mar 04 04:27 PM
SAGAN PAUL	Director	Mar 03 '25	Buy	31.76	31,620	1,004,251	312,027	Mar 04 04:24 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 09 '24	Sale	44.68	529	23,637	20,446	Dec 10 04:08 PM
Klinger Shannon Thyme	Officer	Dec 09 '24	Proposed Sale	44.68	529	23,637		Dec 09 03:18 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 03 '24	Sale	43.30	112	4,849	19,837	Dec 04 05:11 PM
Hoge Stephen	President	Dec 03 '24	Sale	43.30	314	13,595	1,443,904	Dec 04 05:08 PM
Klinger Shannon Thyme	Officer	Dec 03 '24	Proposed Sale	43.30	112	4,849		Dec 03 04:11 PM
Hoge Stephen	Officer	Dec 03 '24	Proposed Sale	43.30	314	13,595		Dec 03 03:23 PM
Mock James M	Chief Financial Officer	Nov 29 '24	Sale	42.79	1,420	60,761	11,066	Dec 02 04:26 PM
Klinger Shannon Thyme	Chief Legal Officer	Nov 29 '24	Sale	42.79	1,418	60,675	19,717	Dec 02 04:19 PM
Hoge Stephen	President	Nov 29 '24	Sale	42.79	291	12,452	1,443,567	Dec 02 04:15 PM
Hoge Stephen	Officer	Nov 29 '24	Proposed Sale	42.79	291	12,452		Nov 29 03:54 PM
Klinger Shannon Thyme	Officer	Nov 29 '24	Proposed Sale	42.79	1,418	60,675		Nov 29 03:49 PM
Mock James M	Officer	Nov 29 '24	Proposed Sale	42.79	1,420	60,761		Nov 29 03:35 PM

PACB

Pacific Biosciences of California Inc

MRNA

Moderna Inc

Upgrade your FINVIZ experience